| 标题 |
 Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet Oncology 作者：Shun Lü; Lin Wu; Hong Jian; Ying Chen; Qiming Wang; et al 出版日期：2022-07-28 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Nole
Kao
LB
OK
Samuel
MchemG
Criminology34
sci_fp
kakao
右子
cnspower
启蒙
笨笨的元绿
冷静
风雨中飘摇
youth
lizishu
xuxi
阮小粒
皖公网安备34019202002308
